Join Free For Buyer|Sign In

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and

You are here:  Home >>  News >>  Top Stories >>  Antibody Production Successfully Induced in the First Batch of Vaccines

Antibody Production Successfully Induced in the First Batch of Vaccines

February 25, 2020 By fmprc

On the afternoon of 22 February, at the 27th local press briefing on the epidemic control of the novel coronavirus disease (COVID-19) in Zhejiang Province, Song Zhiheng, deputy head of the Science and Technology Department of Zhejiang Province, said that the first batch of vaccines has successfully induced antibody production and entered the stage of animal test. The cultivation of recombinant virus for the development of recombinant adenovirus vector vaccine has started, and animal test will begin soon. In Zhejiang Province, scientists are already conducting vaccine research based on the fourth generation of the coronavirus, and they are now racing against time to seek breakthroughs. Despite these positive developments, it is important to recognize that there is a long R&D cycle for vaccines and the law of science must be respected to make sure that the research process is strictly science-based and safe.

Register as Visitor to CPhI China 2020!

Register as Visitor to CPhI China 2020!

Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the reproduced articles,

please email: to motify or remove the content.


Add a comment
Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.
More>> MarketNews
More>> Editors’Picks
More>> TopStories
More>> HotTags
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved). ICP 05034851-53